Review
Open access
Oct 2026
Antibiotics and outcomes of cancer immunotherapy: An updated meta-analysis and clinical applications.
The gut microbiome is a modifiable determinant of response to immune checkpoint inhibitors (ICI), positioning antibiotic exposure as a critical yet under-recognized risk factor for worse survival outcomes in immuno-oncology. As nearly 30% of ICI-treated patients receive antibiotics and indications of cancer immunothera...
Serena Porcari, L. Bolte, J. Björk et al.
· Cancer Cell · 0 citations